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Abstract
Background: In animal studies, remote ischemic preconditioning (RIPC) and anesthetic preconditioning are successful
in reducing renal ischemia reperfusion injury (IRI), however the protective effect of RIPC may be improved by repeating
the RIPC stimulus.
Methods: Sprague-Dawley rats underwent unilateral nephrectomy followed by 30 min of renal pedicle clamping.
Animals were allocated into six groups: sham, control (IRI), RepISO (daily isoflurane anesthesia), RIPC (single dose
isoflurane anesthesia and single dose RIPC), RepISO + RIPC (7-day isoflurane anesthesia and single dose RIPC) and
RepISO + RepRIPC (7-day isoflurane anesthesia with 7-day RIPC). RIPC was applied by 3×5 min of cuff inflation on
both thighs. Serum creatinine and urea levels were measured and histology was obtained at day two.
Results: RepISO diminished renal IRI, as reflected by a significant reduction in serum creatinine levels as compared to
the control group, 170 ± 74 resp. 107 ± 29 μmol/L. The other preconditioning protocols showed similar reduction in
serum creatinine levels as compared to the control group. No significant differences were observed between
the different preconditioning protocols. For urea levels, only RepISO + RIPC resulted in significantly lower levels
as compared to the control group, 14 ± 4 resp. 22 ± 7 mmol/L (p = 0.010). In the preconditioning groups only
RepISO showed less histological damage as compared to controls 1.73 ± 1.19 resp. 2.91 ± 1.22 (p = 0.032).
Conclusions: In this study no additional protective effect of repeated ischemic preconditioning was observed
as compared to single dose RIPC. Repeated administration of isoflurane provided stronger protection against
renal IRI as compared to single dose isoflurane.
Keywords: Anesthetic preconditioning, Animal experiment, Ischemia reperfusion injury, Kidney, Repeated remote
ischemic preconditioning
Background
Ischemia reperfusion injury (IRI) is tissue damage caused
by the restoration of blood flow after a period of deprived
circulation of that tissue [1]. The deficit of oxygen and
nutrients during the ischemic phase creates a condition in
which the return of blood flow induces oxidative stress,
inflammation and results in apoptosis of the cell [2].
This may lead to tissue damage and loss of organ func-
tion [3]. The kidney is an organ especially vulnerable to
IRI, due to its high-energy demand and delicate micro-
circulation. IRI of the kidney is a significant clinical
problem in shock, renal transplantation and major car-
diac or vascular surgery [4]. A promising method to
diminish IRI was first described in 1986 by Murry [5], he
discovered that short harmless periods of ischemia can
protect the heart against a prolonged ischemic period; this
phenomenon is called ischemic preconditioning (IPC). It
was later described that the interruption of blood flow to
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an organ different than the target organ could also have a
protective effect on IRI. This phenomenon is known as
remote ischemic preconditioning (RIPC) [6]. Although the
exact mechanism of RIPC is unknown, prevention of
apoptosis by closure of the mitochondrial permeability
transition pores (mPTP), seems to play a pivotal role [3].
A limb is often used as the remote organ for the applica-
tion of the RIPC stimulus as the blood flow can safely and
easily be obstructed by insufflation of a blood pressure
cuff around an arm or leg. Experimental studies have
shown that RIPC does not only protect against IRI in the
heart, but also in other organs, including the kidney [7].
Not only a distant ischemic impulse can cause renal
protection from IRI, some anesthetics also protect the
kidney against IRI. In myocardial and renal animal stud-
ies, [8] anesthetics have shown to reduce IRI in a similar
signaling cascade as RIPC, known as anesthetic precon-
ditioning (APC). Volatile anesthetics have extensively
been tested for their APC effectiveness in cardiac studies:
isoflurane, sevoflurane, desflurane [9, 10], halothane [11]
and ether derived anesthetics [12] have proven clinical
and preclinical cardioprotective effects. Experiments with
intravenous anesthetics, propofol, barbitarates and keta-
mine [13–15] show no protective effect and have been
demonstrated to inhibit mKATP channels which is an
indication these anesthetics might diminish the protective
effect of APC or RIPC [16]. The effects of multiple periods
of anesthetics on IRI are unknown.
In general, animal studies show that RIPC is effective
in reducing renal IRI [17]; however, human studies show
disappointing results, with a small or non-significant
protective effect [18, 19]. Cumulating evidence exists
that in cardiac IRI models, repeating the RIPC stimulus
over a period of multiple days, repeated RIPC (RepRIPC),
could be more effective as compared to single dose RIPC
[13, 20, 21]. It is unclear if this holds true for renal IRI. In
this study we test whether the null-hypothesis could be
rejected that single dose and repeated RIPC are equally
effective in an experimental model of renal IRI.
Methods
The Committee for Animal Experiments of the Radboud
Medical Center, Nijmegen approved all procedures
(registration number 20149), and the experiment was
conducted according to the ARRIVE criteria. 59 male
Sprague–Dawley rats (Harlan Laboratories, Eystrup,
Germany) were brought into the facility two weeks be-
fore the start of the experiment to acclimatize. Rats from
different groups were housed randomly in the same
room and under standard specific pathogen-free housing
conditions. The environmental temperature was regu-
lated at 22 °C, with a relative humidity of 45% and a 12/
12h day/night cycle. At the start of the experiment the
animals weight was 311 ± 21g, at the age of 10 weeks.
Blinding
Group assignment of each rat was done by computer-
generated randomization. The surgeon, caregivers and
the analysts performing creatinine, urea and histology
measurements were blinded for group assignment of the
animals.
Study design
All animals were anesthetized using isoflurane for the
same period of time and all animals underwent right neph-
rectomy. Animals were randomly divided in six groups
(Fig. 1): Group 1 and 2 underwent no preconditioning.
The sham group (n = 4, group 1) underwent a laparotomy,
including the resection of the right kidney. The control
group (n = 11, group 2) underwent 30 min of left renal
1. Sham (n=4) 
2. Control (n=11)
3. RepISO (n=11) 
4. RIPC (n=11)
5. RepISO+RIPC (n=11) 
6. RepISO+RepRIPC (n=11) 
Fig. 1 Schematic protocol of the animal groups were the line is a non linear timeframe of seven days. The open boxes indicate a period of
anesthesia alone, gray boxes a period or RIPC and black boxes a period of renal ischemia. Animals were randomly allocated into six groups:
sham, control (IRI), RepISO (daily isoflurane anesthesia), RIPC (single dose isoflurane anesthesia and single dose RIPC), RepISO + RIPC (7-day
isoflurane anesthesia and single dose RIPC) and RepISO + RepRIPC (7-day isoflurane anesthesia with 7-day RIPC). RIPC was applied by 3×5 min
of cuff inflation on both thighs
Menting et al. BMC Anesthesiology  (2017) 17:14 Page 2 of 7
ischemia (IRI stimulus) during right kidney resection.
Groups 3–6 were the experimental, preconditioning
groups, all undergoing 30 min of left renal ischemia at the
day of surgery and a specific preconditioning stimulus: In
group 3; repeated isoflurane (RepISO, n = 11), the animals
underwent seven days of isoflurane anesthesia for 25 min
prior to the day of the operation. In group 4; single RIPC
(RIPC, n = 11); the animals underwent 3× 5 min of cuff
inflation and 5 min of reperfusion prior to the operation.
Cuff inflation was initiated by using human toe pressure
cuffs, inflating them simultaneously to 200mmHg on both
thighs. RIPC required 25 min of anesthesia as the last 5
min of reperfusion did not require anesthesia. In group 5;
repeated isoflurane and a single RIPC stimulus (RepISO +
RIPC, n = 11), the animals underwent seven days of
anesthesia for 25 min prior to the day of the operation. On
the day of surgery, during isoflurane anesthesia, 3× 5 min
of cuff inflation on both thighs and 5 min of reperfusion
was performed. In group 6; repeated isoflurane and
repeated RIPC (RepISO + RepRIPC, n = 11), the animals
underwent seven days of anesthesia for 25 min together
with seven days of 3× 5 min of cuff inflation on both
thighs and 5 min of reperfusion.
Surgical procedures
All experiments were randomly performed between 8.00
and 16.00h on Mondays and Tuesdays. Preoperative anal-
gesic [Carprofen, 5mg/kg body weight (b.w.)] was admin-
istered subcutaneously 30 min prior to surgery. Surgical
procedures were conducted using standard aseptic surgi-
cal techniques and all microsurgical instruments were
sterilized using a dry bead sterilizer (Inothech, Dottikon,
Switzerland). Animals were placed on a sterile drape over-
lying a heating pad to maintain body temperature at 36–
38 °C, monitored continuously using a rectal thermom-
eter. Body weights were recorded prior to surgery, prior to
blood collection and at the end of the experiment.
Anesthesia was induced with 5% isoflurane in pressurized
air and maintained at 2.5–3%. Depth of anesthesia was
assessed by toe and tail pinch. Preconditioning was done
by TM. All operations were done by an experienced
microsurgeon (RL), renal ischemia was initiated by blunt
dissection of the left renal hilus, and an atraumatic vascu-
lar clamp was used to obstruct the venous and arterial
blood flow of the kidney. Complete obstruction was con-
firmed by visualization of the kidney gaining the typical
ischemic dark purple color; complete revascularization
after removal of the clamp was also visualized before
closure of the abdomen. Closure of the abdomen was
done by a running suture, securing both ends with a
metal clip to prevent opening of the wound by the animal.
One day post-operatively, an analgesic (Carprofen, 5 mg/
kg b.w.) in 5mL saline was administered subcutaneously.
Renal function analysis and histology
At baseline, day one and day two blood samples were
collected and stored. Blood samples were collected in
EDTA tubes and centrifuged for 15 min at 3000g to
obtain plasma. Plasma was snap frozen in liquid nitrogen
and stored at -80 °C until further use. For the histology,
tissue from the remaining kidney was taken two days
after surgery and was fixed in 4% paraformaldehyde for
at least 48h. For light microscopy of the renal cortex,
kidneys were dehydrated and embedded in paraffin. To
score renal damage, sections of 4 μm were stained with
periodic acid-Schiff. Of each kidney, four sections were
taken at different latitudes and scored for damage of the
renal cortex and averaged. Damage scoring was per-
formed by a blinded investigator, on a scale from 0 to 4
according to the Jablonski scale [22], with 0: no proximal
tubule damaged, and 4: all tubules damaged.
Statistical and power analysis
Serum creatinine levels were used as the primary out-
come measure. Previous experiments have shown that in
our model of 30 min renal injury, serum creatinine levels
in control animals 48h post-operative are on average
290μmol/l, with an average standard deviation of
103μmol/l [23, 24]. We aim to detect a difference in
serum creatinine between the RepISO + RepRIPC and all
the other experimental groups including the control
group of 100μmol/l. Since there are five comparisons we
have adjusted our level of significance for five compari-
sons, using Bonferonni correction: 0.05/5 = 0.01. In
order to achieve a statistical power of at least 80%, we
require 11 animals per group. Previous experiments have
shown that the standard deviation in sham-operated ani-
mals is low (average serum creatinine 48h post-operative
= 46 ± 8). Therefore 4 animals in the sham group were
required. Although the animals were obtained from a dif-
ferent supplier, we estimated that the susceptibility to
renal IRI would be similar because the strain, age, sex and
weight were identical as in the previously mentioned
experiments. All data are presented as mean ± SD unless
otherwise specified. The means of the different groups
were compared using the Student-t test. The level of stat-
istical significance was set at p <0.05. Data were assessed
and SPSS 22 and GraphPath 5.03 plotted graphs.
Results
Peri-operative complications
Fifty-nine rats were randomly assigned to six different
groups. Two rats died during anesthesia. A third animal
was excluded at day two of the experiment due to intes-
tinal rotation with obstruction. A fourth rat was
excluded because the remaining kidney contained a large
tumor, which filled one third of the kidney’s volume.
The excluded rats belonged to different groups: control,
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RepISO, RIPC and RepISO + RepRIPC. The weight of
the animals at baseline and the average weight loss at
day two in the different groups were not significantly
different between the groups.
Renal function analysis
Serum creatinine (Fig. 2) and serum urea concentrations
(Fig. 3) were measured at baseline (ten days before sur-
gery) and on postoperative day one and two. All baseline
outcome measures were not significantly different.
In comparison with the control group, all groups
showed a significantly lower level of creatinine; control
170 ± 74 μmol/L vs. sham and experimental group 1 and
3–6 respectively; 71 ± 16 μmol/L (p = 0.023), 107 ± 29
μmol/L (p = 0.022), 107 ± 45 μmol/L (p = 0.032), 96 ± 22
μmol/L (p = 0.007) and 102 ± 37 μmol/L (p = 0.023). For
the experimental groups only serum creatinine levels of
RepISO on day 1 were significantly higher than sham
creatinine levels; 107 ± 29 μmol/L resp. 71 ± 16 μmol/L
(p = 0.039).
On day two the creatinine concentrations were re-
duced compared with day one and on day two there was
no significant difference between sham and the experi-
mental groups. The control animals showed significantly
higher creatinine concentrations compared with the ex-
perimental groups, RepISO, RepISO + RIPC and RepISO
+ RepRIPC respectively: 102 ± 29 μmol/L vs. 63 ± 21
μmol/L (p = 0.036), 49 ± 8 μmol/L (p = 0.006) and 57 ±
21 μmol/L (p = 0.028).
For urea levels, all groups showed significantly higher
levels on day one as compared to sham: 9 ± 1 mmol/L
vs. control 22 ± 7 mmol/L (p = 0.000), vs. RepISO 18 ± 5
mmol/L (p = 0.000), vs. RIPC 17 ± 8 mmol/L (p = 0.010),
vs. RepISO + RIPC 14 ± 4 mmol/L (p = 0.002) and vs.
RepISO + RepRIPC 17 ± 7 mmol/L (p = 0.047). Com-
pared to control operated animals, only serum urea
levels in RepISO + RIPC were significantly lower, 14 ± 4
vs. 22 ± 7 mmol/L (p = 0.010).
Histology
Histology, according to the Jablonski score, showed sig-
nificantly more renal damage in the control group 2.91
± 1.22 as compared to sham 0.75 ± 0.96 (p = 0.007). In
the preconditioning groups only RepISO, 1.73 ± 1.19
(p = 0.032), showed significantly less damage as com-
pared to control (Fig. 4).
Discussion
To our knowledge this is the first experiment of Rep-
RIPC compared to single dose RIPC in an experimental
renal IRI model. With regard to the primary hypothesis,
we were not able to demonstrate an additive protective
effect of a repeated ischemic preconditioning stimulus in
this experiment. However the question whether an addi-
tive protective effect of RepRIPC does not exist or the
unanticipated large reduction in renal IRI by repeated
isoflurane blurred the additional protective effects of
repeated RIPC, remains unanswered.
Fig. 2 Serum creatinine; day -10 (baseline), 1 and 2 postoperative (* significantly different from sham, # significantly different from control group)
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Results show that all different preconditioning proto-
cols, including RepRIPC, showed a significant reduction
in serum creatinine at day one, which was the primary
outcome measure. However it is important to note that
the observed differences in serum creatinine levels at
day one between the different preconditioning protocols
and the control group (single dose APC) were smaller than
the difference used for the power calculation (100 μmol/L).
This indicates that a smaller difference in serum creatinine
levels would have been more appropriate to reduce the risk
of a type I error. With regard to serum urea levels, only
RepISO +RepRIPC showed a significant reduction as
Fig. 3 Serum urea; day -10 (baseline), 1 and 2 postoperative (* significantly different from sham, # significantly different from control group)
Fig. 4 Histology; day 2 postoperative (* significantly different from sham, # significantly different from control group)
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compared to the control group, receiving a single period of
isoflurane. Probably the number of animals per group was
too small to detect differences in serum urea levels be-
tween RepISO and controls. With regard to the histology
data, only animals in the RepISO group had lower scores
for renal injury as compared to controls. This finding sup-
ports the main observation of this study, repeated adminis-
tration of isolfurane provides stronger protection against
renal IRI as compared to single dose isolfurane.
In this study isoflurane was chosen as an anesthetic
because it is safe, has little side effects and is widely used
in animal studies and in patients. The downside of using
isoflurane in this experiment is the protective effect of
isoflurane on renal IRI. One previous study [8] showed
that single dose isoflurane preconditioning ameliorated
IRI of the kidney. In our study we showed that a 7-day
repeated isoflurane preconditioning provided signifi-
cantly more protection against renal IRI as compared to
single dose isoflurane in the control group. The smallest
number of daily repeated isoflurane preconditioning cycles
providing maximum protection remains unknown. To our
knowledge, the strong protective effects of repeated iso-
flurane administrations over multiple days has not been
described previously.
Another remarkable observation is that 30 min of ped-
icle clamping induced less renal injury as compared to our
previous experiments [23, 24]. As the amount of renal
injury varied between this experiment and previous obser-
vations, it would have been better to include more animals
to control for this variation in our experimental model.
The most likely explanation for the difference with the
previous experiments is that our animals were obtained
from a different supplier. Despite the fact that we used the
same strain, there may have been differences in the gen-
etic makeup leading to a lower susceptibility to renal IRI.
This phenomenon is supported by studies showing that
different strains of mice have a different susceptibility to
cardiac IRI [25, 26]. In this experiment 30 min of IRI was
chosen, despite the fact that 45 min is more commonly
used in similar experiments [17]. The reason to shorten
the IRI period is that the amount of IRI in most animal
studies is relatively large as compared to clinical trials
[17–19, 21, 27]. In our view the induction of a lower
amount of IRI results in a more realistic animal model for
the translation into clinical practice.
Conclusion
IPC has been a promising phenomenon since its discovery
in 1986 [5]; however, the vast amount of IRI protection by
IPC, shown in animal studies, cannot be translated into
clinical trials [17, 19]. Accumulating evidence indicate that
RepRIPC is a promising tool to provide a more effective
and robust RIPC stimulus. RepRIPC was successfully
studied in animal heart models [28, 29], endothelial
dysfunction models in healthy humans [21] coronary
artery bypass grafting [30] and after stroke [20]. Neverthe-
less our results show that it is difficult to establish
additional protection of a repeated RIPC stimulus as
compared to single dose RIPC in animal studies redu-
cing renal IRI. In future animal studies investigating
the mechanisms and/or efficacy of repeated RIPC and
APC, the strong protective effects of the repeated admin-
istration of (volatile) anesthetics, i.e. isoflurane, should be
taken into account.
Abbreviations
APC: Anesthetic preconditioning; IPC: Ischemic preconditioning; IRI: Ischemia
reperfusion injury; mPTP: Mitochondrial permeability transition pores;
RepISO: Repeated isoflurane anesthesia; RepRIPC: Repeated remote ischemic
preconditioning; RIPC: Remote ischemic preconditioning
Acknowledgements
Not applicable.
Funding
This study was financed by the Radboud Medical Center, Nijmegen. The
funding body had no role in the design of the study and collection, analysis,
and interpretation of data and in writing of the manuscript.
Availability of data and materials
The datasets used and analysed during the current study are available from
the corresponding author on reasonable request.
Authors’ contributions
MW and TM initiated and designed the study. TM, MB, ME and RL performed
the experiment, TM and MW analyzed the data. TM wrote the manuscript.
HG, MW, and KW revised the manuscript. All authors read and approved the
final manuscript.
Competing interests
The authors declare that they have no competing interest.
Consent for publication
Not applicable.
Ethics approval
All procedures performed in studies involving animals were in accordance
with the ethical standards of the institution and practice at which the
studies were conducted, in this case the Committee for Animal Experiments
of the Radboud Medical Center Nijmegen approved all procedures
(registration number 20149), and the experiment was conducted according
to the ARRIVE criteria. (https://www.radboudumc.nl/Research/
Organisationofresearch/Departments/cdl/Pages/FacilitiesAndServices.aspx).
Author details
1Department of Surgery, Radboud University Medical Center, Geert
Grooteplein-zuid 10, 6525 GA Nijmegen, The Netherlands. 2Systematic
Review Centre for Laboratory animal Experimentation, SYRCLE, Radboud
University Medical Center, Geert Grooteplein-zuid 10, 6525 GA Nijmegen, The
Netherlands.
Received: 23 July 2016 Accepted: 23 January 2017
References
1. Bonventre JV. Mediators of ischemic renal injury. Annu Rev Med. 1988;39:531–44.
2. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury.
Cardiovasc Res. 1998;38(2):291–300.
3. Ong SB, et al. The mitochondrial permeability transition pore and its role in
myocardial ischemia reperfusion injury. J Mol Cell Cardiol. 2015;78:23–34.
4. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;
351(2):159–69.
Menting et al. BMC Anesthesiology  (2017) 17:14 Page 6 of 7
5. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of
lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124–36.
6. Przyklenk K, et al. Regional ischemic ‘preconditioning’ protects remote virgin
myocardium from subsequent sustained coronary occlusion. Circulation.
1993;87(3):893–9.
7. Cochrane J, et al. Ischemic preconditioning attenuates functional, metabolic,
and morphologic injury from ischemic acute renal failure in the rat. Ren Fail.
1999;21(2):135–45.
8. Liang Y, et al. Isoflurane preconditioning ameliorates renal ischemia-
reperfusion injury through antiinflammatory and antiapoptotic actions in
rats. Biol Pharm Bull. 2014;37(10):1599–605.
9. Muntean DM, et al. Volatile anaesthetics and cardioprotection: lessons from
animal studies. Fundam Clin Pharmacol. 2013;27(1):21–34.
10. Redel A, et al. Comparison of isoflurane-, sevoflurane-, and desflurane-induced
pre- and postconditioning against myocardial infarction in mice in vivo. Exp
Biol Med (Maywood). 2009;234(10):1186–91.
11. Davis RF, et al. The effect of halothane anesthesia on myocardial
necrosis, hemodynamic performance, and regional myocardial blood
flow in dogs following coronary artery occlusion. Anesthesiology. 1983;
59(5):402–11.
12. Zaugg M, et al. Anesthetic cardioprotection in clinical practice from proof-
of-concept to clinical applications. Curr Pharm Des. 2014;20(36):5706–26.
13. Zaugg M, et al. Differential effects of anesthetics on mitochondrial K(ATP)
channel activity and cardiomyocyte protection. Anesthesiology. 2002;
97(1):15–23.
14. Mullenheim J, et al. Ketamine, but not S(+)-ketamine, blocks ischemic
preconditioning in rabbit hearts in vivo. Anesthesiology. 2001;94(4):630–6.
15. Cope DK, et al. Volatile anesthetics protect the ischemic rabbit myocardium
from infarction. Anesthesiology. 1997;86(3):699–709.
16. Kohro S, et al. Anesthetic effects on mitochondrial ATP-sensitive K channel.
Anesthesiology. 2001;95(6):1435–340.
17. Wever KE, et al. Ischemic preconditioning in the animal kidney, a systematic
review and meta-analysis. PLoS One. 2012;7(2):e32296.
18. Hausenloy DJ, et al. Effect of remote ischaemic preconditioning on
myocardial injury in patients undergoing coronary artery bypass graft
surgery: a randomised controlled trial. Lancet. 2007;370(9587):575–9.
19. Walsh SR, et al. Ischaemic preconditioning during cardiac surgery:
systematic review and meta-analysis of perioperative outcomes in
randomised clinical trials. Eur J Cardiothorac Surg. 2008;34(5):985–94.
20. Meng R, et al. Upper limb ischemic preconditioning prevents recurrent
stroke in intracranial arterial stenosis. Neurology. 2012;79(18):1853–61.
21. Jones H, et al. Seven-day remote ischemic preconditioning improves local
and systemic endothelial function and microcirculation in healthy humans.
Am J Hypertens. 2014;27(7):918–25.
22. Jablonski P, et al. An experimental model for assessment of renal recovery
from warm ischemia. Transplantation. 1983;35(3):198–204.
23. Wever KE, et al. Local and remote ischemic postconditionings have
synergistic protective effects on renal ischemia-reperfusion injury.
Transplantation. 2012;94(1):e1–2.
24. Wever KE, et al. Remote ischaemic preconditioning by brief hind limb
ischaemia protects against renal ischaemia-reperfusion injury: the role of
adenosine. Nephrol Dial Transplant. 2011;26(10):3108–17.
25. Burne MJ, et al. Genetic susceptibility to renal ischemia reperfusion injury
revealed in a murine model. Transplantation. 2000;69(5):1023–5.
26. Guo Y, et al. Genetic background, gender, age, body temperature, and
arterial blood pH have a major impact on myocardial infarct size in the
mouse and need to be carefully measured and/or taken into account:
results of a comprehensive analysis of determinants of infarct size in 1,074
mice. Basic Res Cardiol. 2012;107(5):288.
27. Ali ZA, et al. Remote ischemic preconditioning reduces myocardial and
renal injury after elective abdominal aortic aneurysm repair: a randomized
controlled trial. Circulation. 2007;116(11 Suppl):I98–105.
28. Wei M, et al. Repeated remote ischemic postconditioning protects against
adverse left ventricular remodeling and improves survival in a rat model of
myocardial infarction. Circ Res. 2011;108(10):1220–5.
29. Rohailla S, et al. Acute, delayed and chronic remote ischemic conditioning
is associated with downregulation of mTOR and enhanced autophagy
signaling. PLoS One. 2014;9(10):e111291.
30. Liang Y, et al. Long-term, regular remote ischemic preconditioning
improves endothelial function in patients with coronary heart disease. Braz
J Med Biol Res. 2015;48(6):568–76.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Menting et al. BMC Anesthesiology  (2017) 17:14 Page 7 of 7
